Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’
Health Briefs
Related Stories
Health Briefs
Oct 07, 2025
FDA grants Breakthrough Therapy Designation to Angelman Syndrome treatment
Health Briefs
Oct 01, 2025
Dr. Mustafa Sahin gives Cain Labs' Inaugural John Swann Lecture in Epilepsy Series September 29, ...
81681
Health Briefs
Article